Metaboepigenetic regulation of gene expression in obesity and insulin resistance
Metabolomics · 2024
DOI: 10.1007/s11306-024-02159-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolomics, 2024. Verfasst von Swapan K Das und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Endocrinology and Metabolism, Medical Center Boulevard, Wake Forest University School of Medicine, Winsto…. Hauptthemen laut MEDLINE: Insulin Resistance, Obesity, DNA Methylation, Epigenesis, Genetic. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, American Diabetes Association, NIH/NIDDK.
Abstract (Originalsprache)
INTRODUCTION: Variation in DNA methylation (DNAm) in adipose tissue is associated with the pathogenesis of obesity and insulin resistance. The activity of enzymes involved in altering DNAm levels is dependent on several metabolite cofactors. OBJECTIVES: To understand the role of metabolites as mechanistic regulators of epigenetic marks, we tested the association between selected plasma metabolites and DNAm levels in the adipose tissue of African Americans. METHODS: In the AAGMEx cohort (N = 256), plasma levels of metabolites were measured by untargeted liquid chromatography-mass spectrometry; adipose tissue DNAm and transcript levels were measured by reduced representation bisulfite sequencing, and expression microarray, respectively. RESULTS: Among the 21 one-carbon metabolism pathway metabolites evaluated, six were associated with gluco-metabolic traits (PFDR < 0.05, for BMI, SI, or Matsuda index) in AAGMEx. Methylation levels of 196, 116, and 180 CpG-sites were associated (P < 0.0001) with S-adenosylhomocysteine (SAH), cystine, and hypotaurine, respectively. Cis-expression quantitative trait methylation (cis eQTM) analyses suggested the role of metabolite-level-associated CpG sites in regulating the expression of adipose tissue transcripts, including genes in G-protein coupled receptor signaling pathway. Plasma SAH level-associated CpG sites chr19:3403712 and chr19:3403735 were also associated with the expression of G-protein subunit alpha 15 (GNA15) in adipose. The expression of GNA15 was significantly correlated with BMI (β = 1.87, P = 1.9 × 10-16) and SI (β = -1.61, P = 2.49 × 10-5). CONCLUSION: Our study suggests that a subset of metabolites modulates the methylation levels of CpG sites in specific loci and, in turn, regulates the expression of transcripts involved in obesity and insulin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Section of Endocrinology and Metabolism, Medical Center Boulevard, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA. sdas@wakehealth.edu.
- Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Center for Precision Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Förderung
- NIDDK NIH HHS
- American Diabetes Association
- NIH/NIDDK
Zitieren
APA
Das, S. K., Comeau, M. E., & Langefeld, C. D. (2024). Metaboepigenetic regulation of gene expression in obesity and insulin resistance. Metabolomics. https://doi.org/10.1007/s11306-024-02159-2
Vancouver
Das SK, Comeau ME, Langefeld CD. Metaboepigenetic regulation of gene expression in obesity and insulin resistance. Metabolomics. 2024. doi:10.1007/s11306-024-02159-2
BibTeX
@article{Das2024,
author = {Das, Swapan K and Comeau, Mary E and Langefeld, Carl D},
title = {Metaboepigenetic regulation of gene expression in obesity and insulin resistance},
journal = {Metabolomics},
year = {2024},
doi = {10.1007/s11306-024-02159-2}
}
EUVIMED